Scholarly article on 2-((2E,6E,10E)-3,7,11-Trimethyl-12-phenylsulfanyl-dodeca-2,6,10-trienyloxy)-tetrahydro-pyran 71558-13-9 from Journal of the American Chemical Society p. 4401 - 4403

DOI: 10.1021/ja00509a073

Source and publish data:

Journal of the American Chemical Society p. 4401 - 4403 (1979)

Update date:2022-08-03

Topics:

Authors:

Sum,F.W.

Weiler,L.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00509a073

Full text of DOI:10.1021/ja00509a073

Products guided by the article

Product name:2-((2E,6E,10E)-3,7,11-Trimethyl-12-phenylsulfanyl-dodeca-2,6,10-trienyloxy)-tetrahydro-pyran

Cas No:71558-13-9

R&D Labs maybe for 71558-13-9

Tianjin Crest Pharmaceutical R&D Co., Ltd. （Tianjin Yao Technology Development Co., Ltd.）(expird)

Contact:+86-22-66211386

Address:Building B5-405, No, 80 4th Avenue, TEDA, Tianjin, China P.R. 300457
Tianjin Tensing Fine Chemical Research Develop Centre

Contact:86-022-23718576,13032267585

Address:2-2-201,13 Guiyuan road,Huayuan Industry district,Tianjin,china
Jintan City Mego Chemical Co., Ltd

Contact:+86-0519-82814387

Address:23# Dengguan Town, Jintan, Jiangsu Province, China
Simagchem Corporation

website:http://www.simagchem.com

Contact:+86-592-2680277

Address:21/F Hualong Office Building,No.6 Hubin East Road, Xiamen,China
puyang hongda shengdao new material co.,ltd.

Contact:+86-393- 4896278

Address:No.29 East Zhongyuan Road

Relevant to this article

1,3-Dipolar cycloaddition of exo-methylenesugars with nitrone: Approach to new amino-C-ketosyl disaccharides

Doi:10.1016/j.tetlet.2004.03.155
(2004)
THE EFFECT OF ORTHO SUBSTITUENTS IN S_RN1 REACTIONS. SOME SYNTHETIC APPLICATIONS.

Doi:10.1016/S0040-4020(01)97188-1
(1985)
Structure-activity relationships at monoamine transporters for a series of N-substituted 3α-(bis[4-fluorophenyl]methoxy)tropanes: Comparative molecular field analysis, synthesis, and pharmacological evaluation

Doi:10.1021/jm030646c
(2004)
Doi:10.1021/ja00512a028
(1979)
Phenytoin prodrugs III: Water-soluble prodrugs for oral and/or parenteral use

Doi:10.1002/jps.2600730812
(1984)
Doi:10.1016/S0008-6215(00)84767-9
(1979)

Article Doi

DOI: 10.1021/ja00509a073

Source and publish data: